143 445

Cited 6 times in

Interest groups' influence over drug pricing policy reform in South Korea

DC Field Value Language
dc.contributor.author김한중-
dc.contributor.author정우진-
dc.date.accessioned2017-05-04T07:30:12Z-
dc.date.available2017-05-04T07:30:12Z-
dc.date.issued2005-
dc.identifier.issn0513-5796-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/147380-
dc.description.abstractIn 1999, the Korean government made a drug pricing policy reform to improve the efficiency and transparency of the drug distribution system. Yet, its policy formation process was far from being rational. Facing harsh resistance from various interest groups, the government changed its details into something different from what was initially investigated and planned. So far, little evidence supports any improvement in Korea's drug distribution system. Instead, the new drug pricing policy has deteriorated Korea's national health insurance budget, indicating a heavier economic burden for the general public. From Korea's experience, we may draw some lessons for the future development of a better health care system. As a society becomes more pluralistic, the government should come out of authoritarianism and thoroughly prepare in advance for resistance to reform, by making greater efforts to persuade strong interest groups while informing the general public of potential benefits of the reform. Additionally, facing developing civic groups, the government should listen but not rely too much on them at the final stage of the policy formation. Many of the civic groups lack expertise to evaluate the details of policy and tend to act in a somewhat emotional way.-
dc.description.statementOfResponsibilityopen-
dc.format.extent321~330-
dc.languageEnglish-
dc.publisherYonsei University-
dc.relation.isPartOfYONSEI MEDICAL JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHDrug Costs/legislation & jurisprudence*-
dc.subject.MESHHealth Care Reform/economics*-
dc.subject.MESHHealth Care Reform/legislation & jurisprudence*-
dc.subject.MESHHumans-
dc.subject.MESHKorea-
dc.subject.MESHNational Health Programs/economics-
dc.subject.MESHNational Health Programs/legislation & jurisprudence-
dc.subject.MESHPolitics*-
dc.subject.MESHPublic Opinion*-
dc.titleInterest groups' influence over drug pricing policy reform in South Korea-
dc.typeArticle-
dc.publisher.locationKorea (South)-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.collegeGraduate School of Public Health (보건대학원)-
dc.contributor.departmentDept. of Preventive Medicine and Public Health (예방의학교실)-
dc.contributor.departmentGraduate School of Public Health (보건대학원)-
dc.contributor.googleauthorWoojin Chung-
dc.contributor.googleauthorHan Joong Kim-
dc.identifier.doi10.3349/ymj.2005.46.3.321-
dc.contributor.localIdA01102-
dc.contributor.localIdA03670-
dc.relation.journalcodeJ02813-
dc.identifier.eissn1976-2437-
dc.identifier.pmid15988802-
dc.subject.keywordHealth-
dc.subject.keywordreform-
dc.subject.keywordpolicy-
dc.subject.keywordinterest group-
dc.subject.keywordpolitics-
dc.subject.keyworddrug price-
dc.subject.keywordKorea-
dc.contributor.alternativeNameKim, Han Joong-
dc.contributor.alternativeNameChung, Woo Jin-
dc.citation.volume46-
dc.citation.number3-
dc.citation.startPage321-
dc.citation.endPage330-
dc.identifier.bibliographicCitationYONSEI MEDICAL JOURNAL, Vol.46(3) : 321-330, 2005-
dc.date.modified2017-05-04-
dc.identifier.rimsid48552-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers
4. Graduate School of Public Health (보건대학원) > Graduate School of Public Health (보건대학원) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.